Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 429

1.

Transapical aortic valve replacement in extreme-risk patients: outcome, risk factors and mid-term results.

Ferrari E, Namasivayam J, Marcucci C, Gronchi F, Berdajs D, Niclauss L, von Segesser LK.

Eur J Cardiothorac Surg. 2013 May;43(5):978-85. doi: 10.1093/ejcts/ezs458. Epub 2012 Aug 11.

PMID:
22885336
2.

Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.

Nguyen TC, Babaliaros VC, Razavi SA, Kilgo PD, Guyton RA, Devireddy CM, Shults CC, Mavromatis K, Kanitkar M, Block P, Lerakis S, Thourani VH.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1399-406; discussion 13406-7. doi: 10.1016/j.jtcvs.2013.07.065. Epub 2013 Sep 24.

3.

Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.

Onorati F, D'Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L; OBSERVANT Research Group.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):568-75. doi: 10.1016/j.jtcvs.2013.10.006. Epub 2013 Nov 19.

4.

Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.

Ihlberg L, Nissen H, Nielsen NE, Rück A, Busund R, Klaarborg KE, Soendergaard L, Harnek J, Miettinen H, Eskola M, Wahba A, Laine M.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1047-54; discussion 1054. doi: 10.1016/j.jtcvs.2013.06.045. Epub 2013 Aug 30.

5.

Transapical aortic valve implantation: mid-term outcome from the SOURCE registry.

Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M; SOURCE investigators.

Eur J Cardiothorac Surg. 2013 Mar;43(3):505-11; discussion 511-2. doi: 10.1093/ejcts/ezs297. Epub 2012 May 30.

PMID:
22648920
6.

Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).

Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, Douglas PS, Fearon WF, Kirtane AJ, Maniar HS, Passeri JJ; PARTNER Investigators.

Circ Cardiovasc Interv. 2013 Dec;6(6):604-14. doi: 10.1161/CIRCINTERVENTIONS.113.000650. Epub 2013 Nov 12.

7.

Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era.

Iturra SA, Suri RM, Greason KL, Stulak JM, Burkhart HM, Dearani JA, Schaff HV.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):127-32. doi: 10.1016/j.jtcvs.2013.08.036. Epub 2013 Oct 4.

8.

Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.

D'Onofrio A, Rizzoli G, Messina A, Alfieri O, Lorusso R, Salizzoni S, Glauber M, Di Bartolomeo R, Besola L, Rinaldi M, Troise G, Gerosa G.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1065-70; discussion 1070-1. doi: 10.1016/j.jtcvs.2013.06.047. Epub 2013 Sep 8.

9.

Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement?

Zierer A, Wimmer-Greinecker G, Martens S, Moritz A, Doss M.

J Thorac Cardiovasc Surg. 2009 Nov;138(5):1067-72. doi: 10.1016/j.jtcvs.2009.04.057. Epub 2009 Sep 9.

10.

Survival, predictive factors, and causes of mortality following transcatheter aortic valve implantation.

Alassar A, Roy D, Valencia O, Brecker S, Jahangiri M.

Innovations (Phila). 2013 Sep-Oct;8(5):359-63. doi: 10.1097/IMI.0000000000000024.

PMID:
24346585
11.

Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.

Rabus MB, Kirali K, Kayalar N, Tuncer EY, Toker ME, Yakut C.

Anadolu Kardiyol Derg. 2009 Feb;9(1):41-6.

12.

Aortic valve surgery in octogenarians: predictive factors for operative and long-term results.

Kolh P, Kerzmann A, Honore C, Comte L, Limet R.

Eur J Cardiothorac Surg. 2007 Apr;31(4):600-6. Epub 2007 Feb 20.

13.

Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians.

Strauch JT, Scherner M, Haldenwang PL, Madershahian N, Pfister R, Kuhn EW, Liakopoulos OJ, Wippermann J, Wahlers T.

Thorac Cardiovasc Surg. 2012 Jul;60(5):335-42. doi: 10.1055/s-0032-1304538. Epub 2012 Apr 30.

PMID:
22547302
14.

Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.

Shah AM, Ogbara J, Herrmann HC, Fox Z, Kadakia M, Anwaruddin S, Bavaria JE, Desai ND, Jagasia D, Szeto WY, Li RH, Vallabhajosyula P, Giri J.

Catheter Cardiovasc Interv. 2015 Nov;86(5):888-94. doi: 10.1002/ccd.25994. Epub 2015 May 11.

PMID:
25963625
15.

Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta?

Kempfert J, Van Linden A, Linke A, Schuler G, Rastan A, Lehmann S, Lehmkuhl L, Mohr FW, Walther T.

Ann Thorac Surg. 2010 Nov;90(5):1457-61. doi: 10.1016/j.athoracsur.2010.06.080.

PMID:
20971240
16.

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study.

Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group.

Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427. Epub 2010 Nov 12.

17.

The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience.

Hayashida K, Romano M, Lefèvre T, Chevalier B, Farge A, Hovasse T, Le Houerou D, Morice MC.

Eur J Cardiothorac Surg. 2013 Oct;44(4):692-700. doi: 10.1093/ejcts/ezt037. Epub 2013 Feb 24.

PMID:
23439694
18.

Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis.

Humphries KH, Toggweiler S, Rodés-Cabau J, Nombela-Franco L, Dumont E, Wood DA, Willson AB, Binder RK, Freeman M, Lee MK, Gao M, Izadnegahdar M, Ye J, Cheung A, Webb JG.

J Am Coll Cardiol. 2012 Sep 4;60(10):882-6. doi: 10.1016/j.jacc.2012.05.009. Epub 2012 Jul 18.

19.
20.

Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.

Wendler O, Thielmann M, Schroefel H, Rastan A, Treede H, Wahlers T, Eichinger W, Walther T.

Eur J Cardiothorac Surg. 2013 Feb;43(2):371-7. doi: 10.1093/ejcts/ezs203. Epub 2012 Apr 20.

PMID:
22522982

Supplemental Content

Support Center